Chancellor George Osborne has allotted £5.9 billion ($9.2 billion), £1.1 billion per year, over the next parliamentary term to research infrastructure. Half of the £3 billion for supporting labs will be awarded based on competition. “Grand challenges” will receive £2.9 billion. Of that amount, £800 million will go toward projects including chemistry and nanotechnology research, […]
As of the end of October, the US FDA had conducted 97 inspections of the more than 600 pharmaceutical plants in India registered with the US. It found that at many facilities producing medicines for export to the US, samples of drugs failing to meet quality standards for purity were retested rather than discarded. Failed […]
The Russian government’s goals for the sciences call for an update to the country’s scientific system. The goals are for R&D financing to make up 1.77% of GDP, Russian scientific publications to constitute at least 2.44% of the global total and the income of Russian scientists to be 200% that of the average in their […]
With oil prices at a five-year low, down 20% since July, many oil companies are reducing costs. For example, ConocoPhillips will decrease by 20% its 2015 investment spending, and BP plans cuts to jobs over the next several months. However, ConocoPhillips expects its gas and oil production to increase by over 3% next year due […]
The value of the late-stage pipeline of a cohort of 12 major research-based life science companies has risen for the first time since 2010, growing 5.5% to $966 billion in 2014, versus 5.1% in 2013. Although the number of assets has fallen year over year from 194 to 181, the sales potential of the assets […]
In November, the US EPA proposed updates to the National Ambient Air Quality Standards for ground-level ozone. Both the primary (public health) and secondary (public welfare: protecting trees, plants and ecosystems) standards for the average level over any eight-hour period would be 65–70 ppb. Both are currently 75 ppb. Current and proposed federal rules, such […]
Third quarter IBO Life Science Index sales grew 7.0% on a reported and currency-neutral basis, to $3,581 million. Operating profit climbed 12.7% to $762 million. Index results were elevated by Illumina’s performance but partially offset by Bruker. Excluding these two companies, organic sales and adjusted operating profit grew 5.4% and 6.7%, respectively. Based on continuing […]
St. Louis, MO 12/5/14; Washington, DC 12/5/14; Darmstadt, Germany 12/5/14; Darmstadt, Germany 12/8/14—Sigma-Aldrich shareholders have approved the company’s acquisition by Merck KGaA for $17 billion (see IBO 9/30/14). Approximately 78% of shareholders approved the proposal. In connection with the purchase, Merck announced the issuance of a €1.5 billion ($1.8 billion = $1 = €0.81) hybrid […]
Franklin Lakes, NJ 11/4/14; Washington, DC 11/26/14—Becton, Dickinson (BD) realigned its organizational structure, effective October 1, the beginning of its current fiscal year. The company’s reporting segments will be BD Medical, which remains the same, and BD Life Sciences, which combines the former Diagnostics and Biosciences segments.
Lansing, MI 12/8/14—Neogen, which develops and markets products for food and animal safety, has acquired the food-safety and veterinary-genomic assets of Beijing Anapure BioScientific, its Chinese distributor. Financial details were not disclosed. “China’s burgeoning middle class, with its rapidly growing demand for higher quality meat and dairy products, makes the country a substantial growth opportunity […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
